In Vitro and In Vivo Activity of Lucitanib in FGFR1/2 Amplified or Mutated Cancer Models()()

Por Guffanti, Federica, Chilà, Rosaria, Bello, Ezia, Zucchetti, Massimo, Zangarini, Monique, Ceriani, Laura, Ferrari, Mariella, Lupi, Monica, Jacquet-Bescond, Anne, Burbridge, Mike F., Pierrat, Marie-Jeanne, Damia, Giovanna
Publicado no Neoplasia (2016)